4/29/2013

The European Medicines Agency has designated a list of treatments that will be subject to increased oversight. Under Europe's new pharmacovigilance law, the drugs will carry an inverted black triangle on their informational leaflets.

Full Story:
BioSpectrum Asia

Related Summaries